Mandatory implementation of bioequivalence test in drug license eyed

The Korea Food and Drug Administration (KFDA) says it will draft a series of drug-related measures relating to more expanded implementation of bioequivalence test during drug license and re-evaluation on drug necessitating the bioequivalence test until June 12. The KDFA further notes:

- During the annual-phase notice on the ingredients of already-licensed items subject to bioequivalence test...